Delivery Order SPE2DE23D0008-SPE2D625F4ASY
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,092.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division for Inspira SRLP 205CC breast implants. The award, made on September 11, 2025, with an ultimate completion date of September 22, 2025, represents a child delivery order under one of Allergan's larger Indefinite Delivery Vehicle contracts for Natrelle breast implants and surgical devices valued at $13.5 million. The contract utilizes...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order with economic price adjustment on September 2, 2025, for Natrelle Inspira SCM 375CC breast implants. The contract, which carries an ultimate completion date of September 4, 2025, was funded by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical medical devices. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a fixed-price delivery order valued at $3,021.00 for Natrelle Inspira SCLP 300cc breast implants from the Defense Logistics Agency's Medical Supply Chain division. This delivery order, which carries no set-aside designation, was awarded on August 14, 2025, with an ultimate completion date of August 18, 2025, and will be performed at Allergan's facility in Irvine, California. The award reflects Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,075 delivery order by the Defense Logistics Agency Medical Supply Chain on September 11, 2025, for Natrelle Inspira SSF 485CC breast implants with a completion date of September 15, 2025. This fixed-price contract with economic price adjustment will be performed in Irvine, California and does not utilize a set-aside designation. The award represents a child order under one of Allergan's larger indefinite delivery vehicles,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $1,200 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SSF 325CC breast implants. This delivery order, awarded on July 24, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements. The contract does not utilize a set-aside designation, reflecting Allergan's position...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,495.00 on September 2, 2025, for the supply of Natrelle TE Smooth 133S-MX-13-T breast implants. This fixed-price contract with economic price adjustment is funded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support Medical and is scheduled for completion by September 4, 2025. The contract carries no set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of Abbvie Inc., has been awarded a $3,021 fixed-price delivery order by the Defense Logistics Agency Troop Support Medical to supply breast implants. The order is being issued against Allergan's existing $13.5 million Indefinite Delivery Indefinite Quantity contract with the agency, which facilitates the procurement of Allergan's specialty medical devices and implants for use in reconstructive surgeries at Military Treatment Facilities. As the sole-source provider...
- The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a $1,425.00 fixed-price delivery order to Allergan USA Inc., a subsidiary of AbbVie Inc., for the supply of 405cc Natrelle Inspira breast implants. This order is part of a larger $13.5 million Indefinite Delivery Vehicle (IDV) contract that Allergan holds with the Defense Logistics Agency Troop Support Medical for the provision of breast implants, surgical instruments, and related medical items. Allergan also...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $3,404.00 for Natrelle TE Smooth 133S-MX-14-T breast implants on July 24, 2025. This delivery order, issued without set-aside designation, represents a child contract under Allergan's larger Indefinite Delivery Vehicle (IDV) agreements with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is funded through the Medical Supply Chain division of DLA and involves fixed-price...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F4ASYDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation, reflecting Allergan's position as a sole-source supplier of specialized surgical breast implants to the federal government. This delivery order falls under one of Allergan's two significant Indefinite Delivery Vehicle contracts with the Defense Logistics Agency Troop Support Medical, established in December 2022. The $13.5 million IDV for Natrelle breast implants and surgical devices enables electronic ordering and fulfillment across Department of Defense research centers, hospitals, and clinics, supporting reconstructive and aesthetic surgical procedures for military members, veterans, and other eligible populations served by military treatment facilities and the Veterans Health Administration.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/11/25 |